AZN logo

AstraZeneca PLC (AZN) Working Capital

Annual Working Capital:

-$2.04B+$3.45B(+62.85%)
December 31, 2024

Summary

  • As of today, AZN annual working capital is -$2.04 billion, with the most recent change of +$3.45 billion (+62.85%) on December 31, 2024.
  • During the last 3 years, AZN annual working capital has fallen by -$5.69 billion (-155.86%).
  • AZN annual working capital is now -124.44% below its all-time high of $8.34 billion, reached on December 31, 2010.

Performance

AZN Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Quarterly Working Capital:

-$4.60B-$1.61B(-53.75%)
June 30, 2025

Summary

  • As of today, AZN quarterly working capital is -$4.60 billion, with the most recent change of -$1.61 billion (-53.75%) on June 30, 2025.
  • Over the past year, AZN quarterly working capital has dropped by -$1.42 billion (-44.88%).
  • AZN quarterly working capital is now -151.93% below its all-time high of $8.85 billion, reached on June 30, 2011.

Performance

AZN Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

AZN Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+62.9%-44.9%
3Y3 Years-155.9%-411.9%
5Y5 Years+20.2%-41.3%

AZN Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-155.9%+62.9%-159.6%+24.5%
5Y5-Year-155.9%+62.9%-191.0%+24.5%
All-TimeAll-Time-124.4%+62.9%-151.9%+48.1%

AZN Working Capital History

DateAnnualQuarterly
Jun 2025
-
-$4.60B(-53.7%)
Mar 2025
-
-$2.99B(-46.6%)
Dec 2024
-$2.04B(+62.8%)
-$2.04B(-15.1%)
Sep 2024
-
-$1.77B(+44.2%)
Jun 2024
-
-$3.17B(+4.1%)
Mar 2024
-
-$3.31B(+39.7%)
Dec 2023
-$5.49B(-48.3%)
-$5.49B(+9.8%)
Sep 2023
-
-$6.09B(-72.1%)
Jun 2023
-
-$3.54B(-36.3%)
Mar 2023
-
-$2.59B(+29.9%)
Dec 2022
-$3.70B(-201.4%)
-$3.70B(+20.0%)
Sep 2022
-
-$4.63B(-415.1%)
Jun 2022
-
-$898.00M(-865.6%)
Mar 2022
-
-$93.00M(-102.5%)
Dec 2021
$3.65B(+578.4%)
$3.65B(+20.0%)
Sep 2021
-
$3.04B(-39.8%)
Jun 2021
-
$5.05B(+281.9%)
Mar 2021
-
-$2.78B(-264.1%)
Dec 2020
-$763.00M(+70.1%)
-$763.00M(+1.7%)
Sep 2020
-
-$776.00M(+76.1%)
Jun 2020
-
-$3.25B(+22.9%)
Mar 2020
-
-$4.22B(-65.3%)
Dec 2019
-$2.55B(-264.3%)
-$2.55B(-103.3%)
Sep 2019
-
-$1.26B(-54.1%)
Jun 2019
-
-$815.00M(+82.3%)
Mar 2019
-
-$4.61B(-495.2%)
Dec 2018
-$701.00M(+78.3%)
-$774.00M(+63.8%)
Sep 2018
-
-$2.14B(+55.0%)
Jun 2018
-
-$4.75B(+4.6%)
Mar 2018
-
-$4.98B(-42.4%)
Dec 2017
-$3.23B(-62.1%)
-$3.50B(-322.1%)
Sep 2017
-
-$829.00M(+39.0%)
Jun 2017
-
-$1.36B(+64.2%)
Mar 2017
-
-$3.79B(-90.2%)
Dec 2016
-$1.99B(-275.2%)
-$1.99B(+20.7%)
Sep 2016
-
-$2.52B(-151.6%)
Jun 2016
-
-$1.00B(+68.2%)
Mar 2016
-
-$3.15B(-376.6%)
Dec 2015
$1.14B(+279.8%)
$1.14B(+140.1%)
Sep 2015
-
-$2.84B(-21.3%)
Jun 2015
-
-$2.34B(+23.8%)
Mar 2015
-
-$3.07B(-384.5%)
Dec 2014
-$633.00M(-114.8%)
-$633.00M(+15.8%)
Sep 2014
-
-$752.00M(-537.3%)
Jun 2014
-
-$118.00M(+87.8%)
Mar 2014
-
-$971.00M(-124.1%)
Dec 2013
$4.28B(-16.7%)
$4.02B(-2.3%)
Sep 2013
-
$4.12B(-1.9%)
Jun 2013
-
$4.20B(-6.4%)
Mar 2013
-
$4.48B(-8.2%)
Dec 2012
$5.14B(-33.6%)
$4.89B(+25.2%)
Sep 2012
-
$3.90B(-21.6%)
Jun 2012
-
$4.98B(-13.6%)
Mar 2012
-
$5.76B(-23.5%)
Dec 2011
$7.75B
$7.53B(-3.6%)
Sep 2011
-
$7.81B(-11.8%)
Jun 2011
-
$8.85B(+18.8%)
DateAnnualQuarterly
Mar 2011
-
$7.45B(-9.0%)
Dec 2010
$8.34B(+36.3%)
$8.18B(+6.0%)
Sep 2010
-
$7.72B(+9.1%)
Jun 2010
-
$7.07B(+32.1%)
Mar 2010
-
$5.35B(-9.9%)
Dec 2009
$6.12B(+149.4%)
$5.94B(+9.6%)
Sep 2009
-
$5.42B(+36.2%)
Jun 2009
-
$3.98B(+119.2%)
Mar 2009
-
$1.82B(-30.6%)
Dec 2008
$2.45B(+29.5%)
$2.62B(+114.8%)
Sep 2008
-
$1.22B(+103.0%)
Jun 2008
-
$600.43M(+160.5%)
Mar 2008
-
-$992.68M(-159.9%)
Dec 2007
$1.90B(-74.7%)
$1.66B(+297.8%)
Sep 2007
-
-$837.00M(+90.5%)
Jun 2007
-
-$8.86B(-249.1%)
Mar 2007
-
$5.94B(-18.2%)
Dec 2006
$7.49B(+8.1%)
$7.26B(+14.4%)
Sep 2006
-
$6.34B(-4.6%)
Jun 2006
-
$6.65B(+4.7%)
Mar 2006
-
$6.35B(-4.5%)
Dec 2005
$6.93B(+7.7%)
$6.65B(+4.3%)
Sep 2005
-
$6.37B(-4.0%)
Jun 2005
-
$6.64B(+13.4%)
Mar 2005
-
$5.86B(-4.5%)
Dec 2004
$6.44B(+22.9%)
$6.14B(+11.7%)
Sep 2004
-
$5.50B(+11.2%)
Jun 2004
-
$4.94B(+20.8%)
Mar 2004
-
$4.09B(-15.0%)
Dec 2003
$5.24B(+33.9%)
$4.81B(-18.3%)
Sep 2003
-
$5.89B(+15.3%)
Jun 2003
-
$5.11B(+6.8%)
Mar 2003
-
$4.79B(+36.2%)
Dec 2002
$3.91B(+0.7%)
$3.51B(-24.6%)
Sep 2002
-
$4.66B(+2.7%)
Mar 2002
-
$4.53B(+46.9%)
Dec 2001
$3.88B(+7.3%)
$3.09B(-26.2%)
Sep 2001
-
$4.18B(+5.5%)
Jun 2001
-
$3.96B(-2.3%)
Mar 2001
-
$4.06B(+24.3%)
Dec 2000
$3.62B(+25.1%)
$3.27B(-17.1%)
Sep 2000
-
$3.94B(+14.4%)
Jun 2000
-
$3.44B(+3.7%)
Mar 2000
-
$3.32B(+14.7%)
Dec 1999
$2.90B(-22.9%)
$2.90B(-31.2%)
Sep 1999
-
$4.21B(+10.6%)
Jun 1999
-
$3.81B(+1.4%)
Dec 1998
$3.75B(+128.7%)
$3.75B(+152.6%)
Jun 1998
-
$1.49B(-9.5%)
Dec 1997
$1.64B(-17.7%)
$1.64B(-17.7%)
Dec 1996
$2.00B(+14.9%)
$2.00B(+14.9%)
Dec 1995
$1.74B(+9.7%)
$1.74B(-1.2%)
Jun 1995
-
$1.76B(+10.9%)
Dec 1994
$1.58B(+12.8%)
$1.58B(+12.8%)
Dec 1993
$1.40B(+817.5%)
$1.40B
Dec 1992
-$195.65M(-109.6%)
-
Dec 1991
$2.04B(+5.6%)
-
Dec 1990
$1.93B
-

FAQ

  • What is AstraZeneca PLC annual working capital?
  • What is the all-time high annual working capital for AstraZeneca PLC?
  • What is AstraZeneca PLC annual working capital year-on-year change?
  • What is AstraZeneca PLC quarterly working capital?
  • What is the all-time high quarterly working capital for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly working capital year-on-year change?

What is AstraZeneca PLC annual working capital?

The current annual working capital of AZN is -$2.04B

What is the all-time high annual working capital for AstraZeneca PLC?

AstraZeneca PLC all-time high annual working capital is $8.34B

What is AstraZeneca PLC annual working capital year-on-year change?

Over the past year, AZN annual working capital has changed by +$3.45B (+62.85%)

What is AstraZeneca PLC quarterly working capital?

The current quarterly working capital of AZN is -$4.60B

What is the all-time high quarterly working capital for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly working capital is $8.85B

What is AstraZeneca PLC quarterly working capital year-on-year change?

Over the past year, AZN quarterly working capital has changed by -$1.42B (-44.88%)
On this page